{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:25:05Z","timestamp":1790706305421,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1486-0","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:35:36Z","timestamp":1443573336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Mao","family":"Hagihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"1486_CR1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609\u201311.","journal-title":"Br J Dermatol"},{"key":"1486_CR2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","volume":"156","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083\u20134.","journal-title":"Br J Dermatol"},{"key":"1486_CR3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250\u20137.","journal-title":"Semin Cutan Med Surg"},{"key":"1486_CR4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","volume":"33","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33:124\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1486_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","volume":"88","author":"M Ben m\u2019rad","year":"2009","unstructured":"Ben m\u2019rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Med (Baltim). 2009;88:131\u201340.","journal-title":"Med (Baltim)"},{"key":"1486_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","volume":"18","author":"DW Denning","year":"2010","unstructured":"Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol. 2010;18:195\u2013204.","journal-title":"Trends Microbiol"},{"key":"1486_CR7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289\u201397.","journal-title":"Clin Infect Dis"},{"key":"1486_CR8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","volume":"369","author":"ER Kuse","year":"2007","unstructured":"Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet. 2007;369:1519\u201327.","journal-title":"Lancet"},{"key":"1486_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","volume":"1","author":"RJ Hamill","year":"2010","unstructured":"Hamill RJ, Sobel JD, El-Sadr W, Johnson PC, Graybill JR, Javaly K, et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis. 2010;1:225\u201332.","journal-title":"Clin Infect Dis"},{"key":"1486_CR10","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","volume":"4","author":"F Lanternier","year":"2012","unstructured":"Lanternier F, Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, et al. A global analysis of mucormycosis in France: the RetroZygo study (2005\u20132007). Clin Infect Dis. 2012;4:S35\u201343.","journal-title":"Clin Infect Dis"},{"key":"1486_CR11","unstructured":"Liposomal amphotericin B (Ambisome\u00ae) IF. 2015. https:\/\/ds-pharma.jp\/product\/ambisome\/pdf\/ambisome_inj_interv.pdf . Accessed 25 Mar 2015."},{"key":"1486_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","volume":"29","author":"Y Kano","year":"2009","unstructured":"Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am. 2009;29:481\u2013501.","journal-title":"Immunol Allergy Clin North Am"},{"key":"1486_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","volume":"69","author":"MD Moen","year":"2009","unstructured":"Moen MD, Lyseng-Williamson KA, Scott LJ. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs. 2009;69:361\u201392.","journal-title":"Drugs"},{"key":"1486_CR14","first-page":"357","volume":"137","author":"JR Sullivan","year":"2001","unstructured":"Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol. 2001;137:357\u201364.","journal-title":"Arch Dermatol"},{"key":"1486_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1486_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/322668","volume":"33","author":"J Collazos","year":"2001","unstructured":"Collazos J, Mart\u00ednez E, Mayo J, Ibarra S. Pulmonary reactions during treatment with amphotericin B: review of published cases and guidelines for management. Clin Infect Dis. 2001;33:75\u201382.","journal-title":"Clin Infect Dis"},{"key":"1486_CR17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","volume":"157","author":"M Tohyama","year":"2007","unstructured":"Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157:934\u201340.","journal-title":"Br J Dermatol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1486-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:28:51Z","timestamp":1498249731000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1486-0","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"article-number":"510"}}